Uses of immunoconjugates targeting CD138

Details for Australian Patent Application No. 2010244428 (hide)

Owner Biotest AG ImmunoGen, Inc.

Inventors Osterroth, Frank; Uherek, Christoph; Bruecher, Christoph; Daelken, Benjamin; Engling, Andre; Haeder, Thomas; Wartenberg-Demand, Andrea; Niemann, Gabriele; Zuber, Chantal; Czeloth, Niklas; Aigner, Silke; Zeng, Steffen; Schulz, Gregor

Agent Griffith Hack

Pub. Number AU-A-2010244428

PCT Pub. Number WO2010/128087

Priority 61/176,069 06.05.09 US; 61/259,430 09.11.09 US

Filing date 5 May 2010

Wipo publication date 11 November 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/128087 Priority application(s): WO2010/128087

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010244431-A system, method, and luminescent marker for improved diffuse luminescent imaging or tomography in scattering media

2010244406-Closure having an odorous substance